Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QL Block for Post-cesarean Delivery Pain
NCT03261193Phase 3Terminated
- Start
- Sep 2017
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain. Started Sep 2017; status: terminated.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03261193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03261193.